Epilepsy, depression, anxiety, and other neurological illnesses are becoming more common. Increased R&D initiatives for the development of technologically enhanced vagus nerve stimulators are likely to fuel growth in the global vagus nerve stimulators market over the forecast period. The dangers of technical failures and the high cost of vagus nerve stimulators are likely to stymie expansion in the worldwide vagus nerve stimulators market over the forecast period. According to a report published in the peer-reviewed medical journal Epilepsia in April 2017, usage of vagus nerve stimulators is linked to both early and late-stage problems. Microbial infections, dyspnea (shortness of breath), and other early stage issues are common, whereas late stage complications include laryngopharyngeal dysfunction, which occurs in around 66% of patients with implanted vagus nerve stimulators.
According to Coherent Market Insights, Global Vagus Nerve Stimulators Market is estimated to be valued at US$ 628.3 million in 2022 and is expected to exhibit a CAGR of 9.0% over the forecast period (2022-2030).
Market Leaders in the Vagus Nerve Stimulator Industry:
1. LivaNova PLC
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom. On May 2017, LivaNova acquires Caisson Interventional, LLC
2.electroCore, Inc.
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
3. SetPoint Medical Corporation
SetPoint Medical is a privately held clinical-stage healthcare company dedicated to treating patients with chronic autoimmune diseases. The company is developing a novel platform designed to stimulate the vagus nerve to activate the inflammatory reflex to produce a systemic immune-restorative effect. Founded in 2007, headquartered in California, U.S.
4. Parasym Ltd.
Parasym is a medical device company focused on providing innovative neurostimulation products that improve quality of life. Parasym's first commercial product is a medical device that targets stimulation of the Vagus Nerve through a unique non-invasive approach. This device was developed through strong research partnerships, with a vision for the future of bioelectric medicine. Founded in 2015, headquartered in London, U.K.
5. Nervana, LLC
Nirvana Daii Public Company Limited, together with its subsidiaries, develops and sells real estate properties. It also provides construction services; and distributes precast concrete products. The company is headquartered in Bangkok, Thailand. The company was founded
6. BioControl Medical
BioControl Medical, a privately held medical device company headquartered in Yehud, Israel, with offices in New Hope, Minnesota, develops implantable medical devices to treat disorders of the autonomic nervous system. Their objective is to improve quality of life and longevity of patients suffering from heart failure. Founded in 1999.
7. NeurAxis, Inc.
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. The company was founded in 2011 and is based in Versailles, Indiana. On January 2023. Neuraxis, Inc. has filed proposed terms for a $15 million U.S. IPO. The firm is developing neuromodulation technologies for the treatment of various pediatric digestive and nausea conditions.
8. Soterix Medical Inc.
On October 2022. Soterix Medical Inc., a global leader in non-invasive neuromodulation and synergistic brain monitoring technologies, has been awarded a Fast Track grant from the National Institute of Mental Health (NIMH). Soterix Medical develops devices and accessories based on neuromodulation and brain stimulation technologies. The company was founded in 2010 and is based in New York, the United States.
9. Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
*Definition- A vagus nerve stimulator, sometimes known as a brain pacemaker, is a device that generates electrical impulses to stimulate the vagus nerve.
